Stem Cell Transplantation

·MeSH: Myelodysplastic Syndromes

11 drugs in development·7 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)
fulphila	Mylan II B.V. (MYL)
lenalidomide	Mylan II B.V. (MYL)

Phase 3(1)

Drug	Company
nomacopan	Akari Therapeutics Plc (AKTX)

Phase 2(2)

Drug	Company
Bortezomib	Coeptis Therapeutics Holdings Inc. (COEP)
Daratumumab	Coeptis Therapeutics Holdings Inc. (COEP)

Phase 1(2)

Drug	Company
TAK-079	Merus N.V. (MRUS)
Veto Cell	Cell Source, Inc. (CLCS)

Preclinical(3)

Drug	Company
Anti-Rejection Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
fsi-174	Forty Seven, Inc. (FTSV)
Veto Cell technology	Cell Source, Inc. (CLCS)

BioSniper tracks 11 drugs in development for Stem Cell Transplantation across 7 companies.

There are 2 clinical trials targeting Stem Cell Transplantation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.